Deficiency of ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) leads to vulnerability to lipid peroxidation

Neurochemistry International

Volumn 57, Issue 2, 2010, Pages 102-110

  Nagamine, Satoshi ^a,b   Kabuta, Tomohiro ^a   Furuta, Akiko ^a   Yamamoto, Kazuhiro ^a   Takahashi, Akio ^a   Wada, Keiji ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

Tocopherol (vitamin E); Dorsal root ganglion; Gracile axonal dystrophy (gad); Lipid peroxidation; Phosphatidic acid; UCH L1

Indexed keywords

4 HYDROXYNONENAL; ALPHA TOCOPHEROL; UBIQUITIN THIOLESTERASE; UBIQUITIN THIOLESTERASE 1; UNCLASSIFIED DRUG; PHOSPHATIDIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL MEMBRANE; DIET RESTRICTION; ENZYME BINDING; ENZYME DEFICIENCY; ENZYME LOCALIZATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MOTOR DYSFUNCTION; MOUSE; MOUSE STRAIN; NERVE CELL CULTURE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN FUNCTION; SPINAL GANGLION; ANIMAL; CELL CULTURE; CHEMISTRY; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; MUTANT MOUSE STRAIN;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; GANGLIA, SPINAL; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MICE; MICE, MUTANT STRAINS; PHOSPHATIDIC ACIDS; UBIQUITIN THIOLESTERASE;

MUS;

EID: 77953912384     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.04.015     Document Type: Article

References (56)

1. Adachi N., Oyasu M., Taniguchi T., Yamaguchi Y., Takenaka R., Shirai Y., Saito N. Immunocytochemical localization of a neuron-specific diacylglycerol kinase beta and gamma in the developing rat brain. Brain Res. Mol. Brain Res. 2005, 139:288-299.
2. Ahmad I., Suhail M. Protective role of vitamin E on mefenamic acid-induced alterations in erythrocytes. Biochemistry (Mosc.) 2002, 67:945-948.
3. Athanassiadou A., Voutsinas G., Psiouri L., Leroy E., Polymeropoulos M.H., Ilias A., Maniatis G.M., Papapetropoulos T. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. Am. J. Hum. Genet. 1999, 65:555-558.
4. Brindley D.N., Waggoner D.W. Phosphatidate phosphohydrolase and signal transduction. Chem. Phys. Lipids 1996, 80:45-57.
5. Cai D., Netzer W.J., Zhong M., Lin Y., Du G., Frohman M., Foster D.A., Sisodia S.S., Xu H., Gorelick F.S., Greengard P. Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation. Proc. Natl. Acad. Sci. U.S. A. 2006, 103:1941-1946.
6. Cai D., Zhong M., Wang R., Netzer W.J., Shields D., Zheng H., Sisodia S.S., Foster D.A., Gorelick F.S., Xu H., Greengard P. Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1936-1940.
7. Choi J., Levey A.I., Weintraub S.T., Rees H.D., Gearing M., Chin L.S., Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 2004, 279:13256-13264.
8. CLEA Japan, Inc., 2007. CLEA Rodent Diet CE-2 (for breeding and reproduction). http://www.clea-japan.com/Feed/ce2.html.
9. Corrotte M., Chasserot-Golaz S., Huang P., Du G., Ktistakis N.T., Frohman M.A., Vitale N., Bader M.F., Grant N.J. Dynamics and function of phospholipase D and phosphatidic acid during phagocytosis. Traffic 2006, 7:365-377.
10. Davidson W.S., Jonas A., Clayton D.F., George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 1998, 273:9443-9449.
11. Golovko M.Y., Rosenberger T.A., Feddersen S., Faergeman N.J., Murphy E.J. Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. J. Neurochem. 2007, 101:201-211.
12. Gong B., Cao Z., Zheng P., Vitolo O.V., Liu S., Staniszewski A., Moolman D., Zhang H., Shelanski M., Arancio O. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006, 126:775-788.
13. Hagve T.A., Johansen Y., Christophersen B. The effect of n-3 fatty acids on osmotic fragility of rat erythrocytes. Biochim. Biophys. Acta 1991, 1084:251-254.
14. Horie H., Kadoya T., Hikawa N., Sango K., Inoue H., Takeshita K., Asawa R., Hiroi T., Sato M., Yoshioka T., Ishikawa Y. Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy. J. Neurosci. 2004, 24:1873-1880.
15. Imre S.G., Fekete I., Farkas T. Increased proportion of docosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke 1994, 25:2416-2420.
16. Kabuta T., Furuta A., Aoki S., Furuta K., Wada K. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J. Biol. Chem. 2008, 283:23731-23738.
17. Kabuta T., Setsuie R., Mitsui T., Kinugawa A., Sakurai M., Aoki S., Uchida K., Wada K. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum. Mol. Genet. 2008, 17:1482-1496.
18. Khateeb S., Flusser H., Ofir R., Shelef I., Narkis G., Vardi G., Shorer Z., Levy R., Galil A., Elbedour K., Birk O.S. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am. J. Hum. Genet. 2006, 79:942-948.
19. Larsen C.N., Krantz B.A., Wilkinson K.D. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 1998, 37:3358-3368.
20. Liu Y., Fallon L., Lashuel H.A., Liu Z., Lansbury P.T. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 2002, 111:209-218.
21. Liu Y., Zhang Y.W., Wang X., Zhang H., You X., Liao F.F., Xu H. Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1. J. Biol. Chem. 2009, 284:12145-12152.
22. Liu Z., Meray R.K., Grammatopoulos T.N., Fredenburg R.A., Cookson M.R., Liu Y., Logan T., Lansbury P.T. Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4635-4640.
23. Mukoyama M., Yamazaki K., Kikuchi T., Tomita T. Neuropathology of gracile axonal dystrophy (GAD) mouse. An animal model of central distal axonopathy in primary sensory neurons. Acta Neuropathol. 1989, 79:294-299.
24. Nijman S.M., Luna-Vargas M.P., Velds A., Brummelkamp T.R., Dirac A.M., Sixma T.K., Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 123:773-786.
25. Nishikawa K., Li H., Kawamura R., Osaka H., Wang Y.L., Hara Y., Hirokawa T., Manago Y., Amano T., Noda M., et al. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem. Biophys. Res. Commun. 2003, 304:176-183.
26. Osaka H., Wang Y.L., Takada K., Takizawa S., Setsuie R., Li H., Sato Y., Nishikawa K., Sun Y.J., Sakurai M., et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 2003, 12:1945-1958.
27. Perrin R.J., Woods W.S., Clayton D.F., George J.M. Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J. Biol. Chem. 2000, 275:34393-34398.
28. Pettegrew J.W., Panchalingam K., Hamilton R.L., McClure R.J. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 2001, 26:771-782.
29. Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol. Med. 2003, 9:94-101.
30. Pratico D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann. NY Acad. Sci. 2008, 1147:70-78.
31. Ross B.M., Mamalias N., Moszczynska A., Rajput A.H., Kish S.J. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. Neuroscience 2001, 102:899-904.
32. Ross B.M., Moszczynska A., Erlich J., Kish S.J. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. J. Neurochem. 1998, 70:786-793.
33. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10(Suppl.):S10-17.
34. Roy S., Lado B.H., Khanna S., Sen C.K. Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Lett. 2002, 530:17-23.
35. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443:780-786.
36. Saigoh K., Wang Y.L., Suh J.G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T., Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 1999, 23:47-51.
37. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 1997, 68:2092-2097.
38. Scherzer C.R., Feany M.B. Yeast genetics targets lipids in Parkinson's disease. Trends Genet. 2004, 20:273-277.
39. Setsuie R., Wang Y.L., Mochizuki H., Osaka H., Hayakawa H., Ichihara N., Li H., Furuta A., Sano Y., Sun Y.J., et al. Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem. Int. 2007, 50:119-129.
40. Shinzawa K., Sumi H., Ikawa M., Matsuoka Y., Okabe M., Sakoda S., Tsujimoto Y. Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J. Neurosci. 2008, 28:2212-2220.
41. Stockl M., Fischer P., Wanker E., Herrmann A. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J. Mol. Biol. 2008, 375:1394-1404.
42. Sun G.Y. Phospholipids and acyl groups in subcellular fractions from human cerebral cortex. J. Lipid Res. 1973, 14:656-663.
43. Sung J.H., Park S.H., Mastri A.R., Warwick W.J. Axonal dystrophy in the gracile nucleus in congenital biliary atresia and cystic fibrosis (mucoviscidosis): beneficial effect of vitamin E therapy. J. Neuropathol. Exp. Neurol. 1980, 39:584-597.
44. Tai H.C., Schuman E.M. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat. Rev. Neurosci. 2008, 9:826-838.
45. Takahashi T., Yamashita H., Nagano Y., Nakamura T., Kohriyama T., Matsumoto M. Interactions of Synphilin-1 with phospholipids and lipid membranes. FEBS Lett. 2006, 580:4479-4484.
46. Treen M., Uauy R.D., Jameson D.M., Thomas V.L., Hoffman D.R. Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells. Arch. Biochem. Biophys. 1992, 294:564-570.
47. Vatassery G.T., Brin M.F., Fahn S., Kayden H.J., Traber M.G. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats. J. Neurochem. 1988, 51:621-623.
48. Wang Y.L., Takeda A., Osaka H., Hara Y., Furuta A., Setsuie R., Sun Y.J., Kwon J., Sato Y., Sakurai M., et al. Accumulation of beta- and gamma-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse. Brain Res. 2004, 1019:1-9.
49. Wells K., Farooqui A.A., Liss L., Horrocks L.A. Neural membrane phospholipids in Alzheimer disease. Neurochem. Res. 1995, 20:1329-1333.
50. Wilkinson K.D., Lee K.M., Deshpande S., Duerksen-Hughes P., Boss J.M., Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989, 246:670-673.
51. Yamazaki K., Wakasugi N., Tomita T., Kikuchi T., Mukoyama M., Ando K. Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse. Proc. Soc. Exp. Biol. Med. 1988, 187:209-215.
52. Yao J.K., Wengenack T.M., Curran G.L., Poduslo J.F. Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice. Neurochem. Res. 2009, 34:102-108.
53. Yokota T., Igarashi K., Uchihara T., Jishage K., Tomita H., Inaba A., Li Y., Arita M., Suzuki H., Mizusawa H., Arai H. Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15185-15190.
54. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:2696-2701.
55. Zhao C., Du G., Skowronek K., Frohman M.A., Bar-Sagi D. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat. Cell Biol. 2007, 9:706-712.
56. Zhou C., Huang Y., Przedborski S. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. NY Acad. Sci. 2008, 1147:93-104.